LensAR Inc. of Orlando, Fla., has received 510(k) clearance from the FDA for its next-generation LensAR Laser System for use in anterior capsulotomy, with and without laser phacofragmentation during cataract surgery. The regulatory action covers the new system, which is in final preparation for commercial launch in the US. The system combines the latest laser technology with product features intended to improve surgeon and patient interactions with it. Enhancements include 3-D imaging measurement and beam-guided delivery that generates a personalized surgical treatment plan.